Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANTI study of BAY 1753011 in heart failure with fluid overload
MOH_2019-07-07_005939Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pecavaptan in heart failure (HF) (4 arms), sponsored by Bayer. Started Apr 2019; status: completed.
02
Drugs
pecavaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on MOH_2019-07-07_005939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-07-07_005939.